Home > Articles > Health > Vision > Intravitreous Pegaptanib Could Halt Vision Loss

Intravitreous Pegaptanib Could Halt Vision Loss

Featured on: Med Page Today
Publication date: Apr 15, 2009

Continued vision loss from central retinal vein occlusion could be prevented by intravitreous injections of pegaptanib (Macugen), research shows. The treatment does not appear to reverse the condition, however. Central retinal vein occlusion is caused by hemorrhage, swelling, and other pressure-related retinal damage when blood backs up in the blocked vein.

Read Full Article

More Vision Articles

Macular Degeneration Hope
Technique Can Stop Macular Degeneration
'Eat Spinach For Healthy Eyes'
Third Of Young Dyslexia Sufferers 'have Treatable Eye Problems'
Lots Of Red Meat Can Harm Vision: Report
Roche Drug Helps Improve Vision
Eye 'compensates For Blind Spot'
Viagra Turned My Sight Blue
How To Protect Your Eyes
Saffron Can Protect Against Eyesight Loss

Not a member? Join now. Membership is free and packed with perks.

Chatterbean's Mission
Our free quizzes are fun to take while you take a break from work or during your free time, but they can also help you learn more about your personality, your lifestyle, and your health. Whether you stop by our site to take a personality quiz, IQ quiz, parenting quiz, love and sex quiz, health quiz, beauty and style quiz, or to create your own quiz, we aim to make you smile.

The material on this site is for informational purposes only, and is intended as a supplement, not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. More.

Polls on this site are for entertainment purposes only and are not scientific. Chatterbean is not responsible for the opinions expressed in polls.